Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Restructuring Costs: 2021-2022

Historic Restructuring Costs for ADC Therapeutics (ADCT) over the last 1 years, with Sep 2022 value amounting to $1,898.

  • ADC Therapeutics' Restructuring Costs rose 126.41% to $1,898 in Q3 2022 from the same period last year, while for Sep 2022 it was $7.0 million, marking a year-over-year change of. This contributed to the annual value of $7.0 million for FY2021, which is N/A change from last year.
  • Per ADC Therapeutics' latest filing, its Restructuring Costs stood at $1,898 for Q3 2022, which was down 0.00% from $1,898 recorded in Q2 2022.
  • In the past 5 years, ADC Therapeutics' Restructuring Costs ranged from a high of $7.0 million in Q1 2022 and a low of -$7,187 during Q3 2021.
  • For the 2-year period, ADC Therapeutics' Restructuring Costs averaged around $1.7 million, with its median value being $1,898 (2022).
  • Data for ADC Therapeutics' Restructuring Costs shows a peak YoY spiked of 126.41% (in 2022) over the last 5 years.
  • Quarterly analysis of 2 years shows ADC Therapeutics' Restructuring Costs stood at -$7,187 in 2021, then skyrocketed by 126.41% to $1,898 in 2022.
  • Its last three reported values are $1,898 in Q3 2022, $1,898 for Q2 2022, and $7.0 million during Q1 2022.